1. Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS-COV-2.
- Author
-
Kelesoglu S, Yilmaz Y, Ozkan E, Calapkorur B, Dursun ZB, Ulu-Kilic A, and Elcık D
- Subjects
- Aged, Atrial Fibrillation complications, COVID-19 virology, Female, Humans, Male, Middle Aged, SARS-CoV-2 isolation & purification, Turkey, Albumins metabolism, Atrial Fibrillation metabolism, C-Reactive Protein metabolism, COVID-19 complications
- Abstract
Aim: To investigate whether C-reactive protein/albumin ratio (CAR) has an association with new onset atrial fibrillation (NOAF) in SARS-CoV-2. Materials & methods: This study included 782 patients with SARS-CoV-2 infection, who were hospitalized in Turkey. The end point of the study was an occurrence of NOAF. Results: NOAF was identified in 41 patients (5.2%). Subjects who developed NOAF had a higher CAR compared with those who did not develop NOAF (p < 0.001). In the multivariate logistic regression analysis the CAR (odds ratio = 2.879; 95% CI: 1.063-7.793; p = 0.037) was an independent predictor of NOAF. Conclusion: A high level of CAR in blood samples is associated with an increased risk of developing NOAF in SARS-CoV-2.
- Published
- 2021
- Full Text
- View/download PDF